Sirona Biochem (CVE:SBM) Stock Price Down 18.8% – Here’s What Happened

Sirona Biochem Corp. (CVE:SBM)’s share price was down 18.8% during trading on Tuesday . The stock traded as low as C$0.07 and last traded at C$0.07. Approximately 112,944 shares were traded during mid-day trading, an increase of 44% from the average daily volume of 78,445 shares. The stock had previously closed at C$0.08.

Sirona Biochem Stock Down 18.8 %

The company has a debt-to-equity ratio of 219.21, a quick ratio of 2.41 and a current ratio of 0.34. The firm has a market cap of C$16.69 million, a price-to-earnings ratio of -6.50 and a beta of -0.03. The business’s 50 day moving average price is C$0.07 and its 200 day moving average price is C$0.06.

Sirona Biochem Company Profile

Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.